» Articles » PMID: 38954839

Neuroretinal Alterations in Schizophrenia and Bipolar Disorder: An Updated Meta-analysis

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2024 Jul 2
PMID 38954839
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia (SZ) and bipolar disorder (BD) are characterized by major symptomatic, cognitive, and neuroanatomical changes. Recent studies have used optical coherence tomography (OCT) to investigate retinal changes in SZ and BD, but their unique and shared changes require further evaluation. Articles were identified using PubMed and Google Scholar. 39 studies met the inclusion criteria. Diagnostic groups were proband (SZ/BD combined), SZ, BD, and healthy control (HC) eyes. Meta-analyses utilized fixed and random effects models when appropriate, and publication bias was corrected using trim-and-fill analysis ("meta" package in R). Results are reported as standardized mean differences with 95% CIs. Data from 3145 patient eyes (1956 SZ, 1189 BD) and 3135 HC eyes were included. Studies identified thinning of the peripapillary retinal nerve fiber layer (pRNFL, overall and in 2 subregions), m-Retina (overall and all subregions), mGCL-IPL, mIPL, and mRPE in SZ patients. BD showed thinning of the pRNFL (overall and in each subregion), pGCC, and macular Retina (in 5 subregions), but no changes in thickness or volume for the total retina. Neither SZ nor BD patients demonstrated significant changes in the fovea, mRNFL, mGCL, mGCC, mINL, mOPL, mONL, or choroid thicknesses. Moderating effects of age, illness duration, and smoking on retinal structures were identified. This meta-analysis builds upon previous literature in this field by incorporating recent OCT studies and examining both peripapillary and macular retinal regions with respect to psychotic disorders. Overall, this meta-analysis demonstrated both peripapillary and macular structural retinal abnormalities in people with SZ or BD compared with HCs.

Citing Articles

Neuroanatomical Deficits in Visual Cortex Subregions of Individuals with Psychosis Spectrum Disorders linked to Symptoms, Cognition, and Childhood Trauma.

Turkozer H, Zeng V, Hoang D, Sritharan J, Iska N, Ivleva E medRxiv. 2025; .

PMID: 39990589 PMC: 11844584. DOI: 10.1101/2025.02.12.25322031.


Genetic Analysis of Retinal Cell Types in Neuropsychiatric Disorders.

Boudriot E, Stephan M, Rabe F, Smigielski L, Schmitt A, Falkai P JAMA Psychiatry. 2025; 82(3):285-295.

PMID: 39775833 PMC: 11883512. DOI: 10.1001/jamapsychiatry.2024.4230.


On the improvement of schizophrenia detection with optical coherence tomography data using deep neural networks and aggregation functions.

Karczmarek P, Plechawska-Wojcik M, Kiersztyn A, Domagala A, Wolinska A, Silverstein S Sci Rep. 2024; 14(1):31903.

PMID: 39738322 PMC: 11685438. DOI: 10.1038/s41598-024-83375-7.


Thinning of central foveal thickness in the retina of patients with schizophrenia.

Zhu J, Wang Z, Chen T, Zhou Y, Xu F, Du J Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 39645616 DOI: 10.1007/s00406-024-01943-4.

References
1.
Brown G, Eyler L . Methodological and conceptual issues in functional magnetic resonance imaging: applications to schizophrenia research. Annu Rev Clin Psychol. 2007; 2:51-81. DOI: 10.1146/annurev.clinpsy.2.022305.095241. View

2.
Meier M, Shalev I, Moffitt T, Kapur S, Keefe R, Wong T . Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry. 2013; 170(12):1451-9. PMC: 3857729. DOI: 10.1176/appi.ajp.2013.13020234. View

3.
Hosak L, Zeman T, Studnicka J, Stepanov A, Ustohal L, Michalec M . Retinal arteriolar and venular diameters are widened in patients with schizophrenia. Psychiatry Clin Neurosci. 2020; 74(11):619-621. DOI: 10.1111/pcn.13123. View

4.
De Peri L, Crescini A, Deste G, Fusar-Poli P, Sacchetti E, Vita A . Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies. Curr Pharm Des. 2012; 18(4):486-94. DOI: 10.2174/138161212799316253. View

5.
Hawkins B, Davis T . The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005; 57(2):173-85. DOI: 10.1124/pr.57.2.4. View